Synergistic Induction of CTLA-4 Expression by Costimulation with TCR Plus CD28 Signals Mediated by Increased Transcription and Messenger Ribonucleic Acid Stability

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4074-4081

  Finn, Patrick W ^a,d   He, Hougzhen ^a,d   Wang, Yungsherg ^b,d   Wang, Zemin ^a,d   Guan, Gumin ^a,d   Listman, James ^c,d   Perkins, David L ^b,d  

^a Pulmonary Division   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; CD28 ANTIGEN; CYCLOHEXIMIDE; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; POLYENE; PROTEIN SYNTHESIS INHIBITOR; RAPAMYCIN;

ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CELL LINE; CYCLOHEXIMIDE; CYCLOSPORINE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNOCONJUGATES; MICE; POLYENES; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; SIROLIMUS; TRANSCRIPTION, GENETIC;

EID: 0031132467     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
2. Liu, Y., and P. S. Linsley. 1992. Costimulation of T-cell growth. Curr. Opin. Immunol. 4:265.
3. Allison, J. P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414.
4. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupance. Annu. Rev. Immunol. 7:445.
5. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
6. Brunet, J., F. Denizot, M. Luciani, M. Roux-Dosseto, M. Suzan, M. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily: CTLA-4. Nature 328:267.
7. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
8. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
9. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
10. Harper, K., C. Balzano, E. Rouvier, M. Mattei, M. Luciani, and P. Golstein. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1037.
11. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. DalCanto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
12. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activaled T lymphocytes. J. Exp. Med. 176:1595.
13. Freeman, G. J., D. B. Lombard, C. D. Gimmi, S. A. Brod, K. Lee, J. C. Lannig, D. A. Haffler, M. E. Dorf, G. S. Gray, H. Reiser, C. H. June, C. B. Thompson, and L. M. Nadler. 1992. CTLA-4 and CD28 messenger RNA are coexpressed in most T cells after activation: expression of CTLA-4 and CD28 messenger RNA does not correlate with the pattern of lymphokine production. J. Immunol. 149:3795.
14. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 5:541.
15. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
16. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
17. Leach, D. R., M. F. Krummel, and J. P. Allison. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1714.
18. Perkins, D. L., Z. Wang, C. E. Donovan, H. He, G. Guan, T. L. Walunas, J. A. Bluestone, J. A. Listman, and P. W. Finn. 1996. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156:4154.
19. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
20. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84: 1374.
21. + splenic T cells after CD28 receptor ligation. J. Immunol. 154:985.
22. Dialynas, D., Z. Quan, K. Wall, A. Pierres, J. Quintans, M. Loken, M. Pierres, and F. Fitch. 1983. Characterization of the murine T cell surface molecule designated L3T4, identified by monoclonal antibody GK-1.5: similarity of L3T4 to the human Leu3/T4 molecule and the possible involvement of L3T4 in class II MHC antigen reactivity. J. Immunol. 133:2445.
23. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1993. Current protocols in molecular biology. John Wiley & Sons, NY.
24. DeWet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725.
25. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 142:138.
26. Rao, A. 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 146:274.
27. Chung, J., C. J. Kuo, G. R. Crabtree, and J. Blenis. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell 69:1227.
28. Price, D. J., J. R. Grove, V. Calvo, J. Avruch, and B. E. Bierer. 1992. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257:973.
29. DeGroot, R. P., L. M. Ballou, and P. Sassone-Corsi. 1994. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 79:81.
30. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
31. 1. J. Biol. Chem. 268:22825.
32. 1-arresting rapamycin-receptor complex. Nature 369:756.
33. Kuo, C. J., J. Chung, D. F. Fiorentino, M. Flanagan, J. Blenis, and G. R. Crabtree. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358:70.
34. Calvo, V., C. M. Crews, T. A. Vik, and B. E. Bierer. 1992. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 89:7571.
35. Pai, S. Y., V. Calvo, M. Wood, and B. E. Bierer. 1994. Cross-linking CD28 leads to activation of 70-kDa S6 kinase. Eur. J. Immunol. 24:2364.
36. Lindsten, T., K. P. Lee, E. S. Harris, B. Petryniak, N. Craighead, P. J. Reynolds, D. B. Lombard, G. J. Freeman, L. M. Nadler, G. S. Gray, C. B. Thompson, and C. H. June. 1993. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151:3489.
37. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
38. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB like response element. J. Biol. Chem. 266:14179.
39. Lai, J. H., G. Horvath, Y. Li, and T. H. Tan. 1995. Mechanisms of enhanced nuclear translocation of the transcription factors c-Rel and NF-kappa B by CD28 costimulation in human T lymphocytes. Ann. NY Acad. Sci. 766:220.
40. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659.
41. Leung, H. T., J. Bradshaw, J. S. Cleaveland, and P. S. Linsley. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270:25107.
42. Linsley, P. S., J. Bradshaw, J. Greene, R. Peach, K. L. Bennett, and R. S. Mittler. 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4:535.
43. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
44. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
45. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
46. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.